Retirement Capital Strategies’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Retirement Capital Strategies’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-79,806	Closed	-$3.5M	–	71
2021 Q4	$3.5M	Sell	79,806 -5,581	-7%	-$264K	1.28%	18
2021 Q3	$4.33M	Sell	85,387 -87,147	-51%	-$4.54M	1.66%	17
2021 Q2	$8.98M	Buy	172,534 +84,485	+96%	+$3.97M	3.42%	8
2021 Q1	$4.03M	Sell	88,049 -4,125	-4%	-$202K	1.59%	20
2020 Q4	$4.23M	Sell	92,174 -1,470	-2%	-$63.5K	1.72%	19
2020 Q3	$3.55M	Sell	93,644 -155,788	-62%	-$5.99M	1.64%	22
2020 Q2	$9.47M	Buy	+249,432	New	+$8.42M	4.5%	7

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Retirement Capital Strategies's IDNA Position: Q1 2022 in Review

Retirement Capital Strategies sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 79,806 shares — an estimated $3.5M sold.

Retirement Capital Strategies first reported a position in IDNA in Q2 2020 and held it in 7 quarters. The position peaked at $9.47M in Q2 2020. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

Retirement Capital Strategies reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
Retirement Capital Strategies sold 79,806 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $3.5M.
Retirement Capital Strategies first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and held it in 7 quarters.
Retirement Capital Strategies's iShares Genomics Immunology and Healthcare ETF position peaked at $9.47M in Q2 2020.
86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Retirement Capital Strategies's 13F filing for Q1 2022, filed 21 Apr 2022.